Echinacea purpurea herba

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 03.08.2023

Dieser Artikel auf Deutsch

Synonym(s)

Echinacea; Echinaceae purpureae herb (engl.); Herba Echinaceae purpureae; Purple coneflower

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Echinaceae purpureae herba, is an officinal preparation (Ph.Eur.8; Monograph: Commission E,WHO, ESCOP) from the whole or cut aerial parts of the plant, see under Echinacea
Quality is defined in the European Pharmacopoeia (Ph. Eur.).:

HMPC monograph: well-established use: Internal: Prevention and therapy of colds. External: Traditional-use: Superficial wounds.

ESCOP mon ograph: Internal: recurrent upper respiratory (common cold) and urinary tract infections; External: superficial wounds.
Commission E monograph: recurrent respiratory and urinary tract infections.

Empirical medicine: herpes simplex (external), adjuvant in tumor diseases.

IngredientsThis section has been translated automatically.

Caffeic acid derivatives (caftaric acid, chicory acid), flavonoids, essential oil, polysaccharides, etc.

EffectsThis section has been translated automatically.

Promotion of wound healing, increase in phagocytosis of granulocytes, activation of fibroblasts, antiphlogistic, non-specific immune modulation.

Spectrum of actionThis section has been translated automatically.

Internal: supportive therapy for recurrence infections of the urinary and respiratory tract. Also for prophylaxis of infections.
External: Supportive therapy for chronic wounds with poor healing

Undesirable effectsThis section has been translated automatically.

With parenteral application, dose-dependent fever reactions, also nausea and vomiting. Allergic reactions possible with parenteral application. Caution with atopics!
In case of application > 8 weeks possibly liver-toxic!

ContraindicationThis section has been translated automatically.

Allergy to one of the ingredients. For fundamental considerations, not to be used in progressive systemic diseases. HIV infection, multiple sclerosis, autoimmune diseases.
No sufficient data for safety in pregnancy and lactation, the sparse data to date (several hundreds of exposed pregnancies): no adverse effects on pregnancy or fetal/neonatal health.

Do not apply externally to the breast in nursing mothers!

Children under 12 years due to lack of data. Pregnancy and lactation due to lack of data

Trade namesThis section has been translated automatically.

Cefatox effervescent tablets, 1-0-1/dayEchinacin
Liquidum Madaus, initial 2.5ml, then 1.25ml every 1-2 hoursEchinacin
Juice Madaus, 5-5-5 ml/dayEsberitox
mono tablets/drops (dosage according to instructions)

Furthermore, combination preparations of Echinacea pallida root + Echinacea purpura root + wild indigo root (Esberitox N solution/tablets)

Note(s)This section has been translated automatically.

Do not combine with immunosuppressants!

LiteratureThis section has been translated automatically.

  1. Ardjomand-Woelkart K et al. (2016) Review and Assessment of Medicinal Safety Data of Orally Used Echinacea Preparations. Planta Med 82(1-2):17-31.
  2. Manayi A et al. (2015) Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. Pharmacogn Rev 9:63-72.
  3. Goey AK et al (2013) The effect of Echinacea purpurea on the pharmacokinetics of docetaxel. Br J Clin Pharmacol 76:467-474.
  4. Moltó J et al (2012) Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients. Antimicrob Agents Chemother 56:5328-5331.
  5. Izzo AA (2012) Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract 21:404-428.
  6. Yamada K et al (2011) A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and Brahmi. J Ethnopharmacol 137:231-235.
  7. hhttps://arzneipflanzenlexikon.info/echinacea.php.
  8. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
  9. Wenigmann M. (2017) Phytotherapy medicinal drugs, phytopharmaceuticals, application. Urban & Fischer, pp. 176-177
  10. Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 9;158(20):2200-2211. doi: 10.1001/archinte.158.20.2200. PMID: 9818800.

Authors

Last updated on: 03.08.2023